Newsinc24 Team 
The DRDO has said that its anti-Covid drug 2-deoxy-D-Gluclose or 2 DG can be given to patients under the care and prescription of doctors as it issued directions for its use. "Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe COVID patients for a maximum duration of up to 10 days," DRDO said on Tuesday. Patients of uncontrolled diabetes, severe cardiac problem, acute respiratory distress syndrome (ARDS), severe hepatic and renal impairment have not been studied yet with 2-DG, and hence caution should be exercised, DRDO said. It added that 2-DG should not be given to pregnant and lactating women and patients below 18 years. "Patients and attendants are advised to request the hospital to contact Dr Reddy's lab Hyderabad for medicine supply at email: 2DG@drreddys.com," the organisation said in a tweet.
The 2DG medicine can be given to Covid-19 patients under the care and prescription of doctors. Directions for usage of this drug for Covid-19 patients as per DCGI approval are attached here for reference. For all queries regarding #2DG, please write to 2DG@drreddys.com pic.twitter.com/x19ayBoToG
— DRDO (@DRDO_India) June 1, 2021
Related Items
DRDO successfully tests indigenous UAV missile in dual combat modes
NCB makes first-ever seizure of ‘Jihadi Drug’ Captagon
DRDO & IAF successfully conduct maiden trial of indigenous TARA glide weapon